| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0009 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.001 |